Thalidomide as an anti-TNF-α inhibitor: Implications for clinical use

Clinical Immunology and Immunopathology

Volumn 81, Issue 3, 1996, Pages 219-223

  Klausner, Jeffrey D ^a   Freedman, Victoria H ^a   Kaplan, Gilla ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEPROSY; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 0030560905     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0181     Document Type: Review

References (37)

1. 1. Kunz, W., Keller, H., and Muckter, H., N-Phthalyl-glutaminsaure-imid: Experimentelle untersuchungen an einem neuen synthetischen produkt mit sedativen eigenenschaften. Arzneim. Forsch. 6, 426-430, 1956.
2. 2. Mellin, G. W., and Katzenstein, M., The saga of thalidomide. New England J. Med. 267, 1184-1193; 1238-1244, 1962.
3. 2. Mellin, G. W., and Katzenstein, M., The saga of thalidomide. New England J. Med. 267, 1184-1193; 1238-1244, 1962.
4. 3. Sheskin, J., Thalidomide in the treatment of lepra reactions. Clin. Pharmacol. Ther. 6(3), 303-306, 1965.
5. 4. Pearson, J. M. H., and Vedagiri, M., Treatment of moderately severe erythema nodosum leprosum with thalidomide - a double-blind controlled trial. Lepr. Rev. 40, 111-116, 1969.
6. 5. Iyer, C. G. S., Languillon, I., Ramanujam, K., Tarabini-Castellani, G., De Ias Aguas, J. T., Bechelli, L. M., Uenura, K., Martinez Dominguez, V., and Sundaresa, T. WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromaous patients. Bull. W. H. O. 45, 719-732, 1971.
7. 6. Barnhill, R. L., and McDougall, A. C., Thalidomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J. Am. Acad. Dermatol. 7, 317-323, 1982.
8. 7. Kaplan, G., and Cohn, Z. A., Leprosy a model for cell-mediated immunity: The effects and consequences of recombinant lymphokine immunotherapy. In "Mononuclear Phagocytes: Biology of Monocytes and Macrophages" (R. van Furth, Ed.), pp. 644-648, Kluwer Academic, Dordrecht/Norwell, MA, 1992.
9. 8. Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., and Kaplan, G., Thalidomide selectively inhibits tumor necrosis factor-α production by stimulated human monocytes. J. Exp. Med. 173, 699-703, 1991.
10. 9. Sampaio, E. P., Moreira, A. L., Sarno, E. N., Malta, A. M., and Kaplan, G., Prolonged treatment with recombinant interferon induces erythema nodosum leprosum in lepromatous leprosy patients. J. Exp. Med. 175, 1729-1737, 1992.
11. 10. Sarno, E. N., Grau, G. E., Vieira, L. M. M., and Nery, J. A., Serum levels of tumor necrosis factor-α and interleukin-1β during leprosy reactional states. Clin. Exp. Immunol. 84, 103-108, 1991.
12. 11. Sampaio, E. P., Kaplan, G., Miranda, A., et al., The influence of thalidomide on the clinical and immunological manifestation of erythema nodosum leprosum. J. Infect. Dis. 168, 408-414, 1993.
13. 11a. Sampaio, E. P., Kaplan, G., Miranda, A., Nery, J. A. C., Miguel, C., Viana, S. M., and Sarno, E. N., Int. J. Lepr., in press.
14. 12. Barnes, P. F., Fong, S. J., Brennan, P. J., Twomey, P. E., Mazumder, A., and Modlin, R. L., Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145, 149-154, 1990.
15. 13. Kaplan, G., and Moreira, A., TNF-α regulation of HIV-1: Biology and therapy. Res. Immunol. 145, 685-690, 1994.
16. 14. Valone, S. E., Rich, E. A., Wallis, R. S., and Ellner, J. J., Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect. Immun. 56, 3313-3315, 1988.
17. 15. Moreno, C., Taverne, J., Mehlert, A., Bate, C. A., Brealey, R. J., Meager, A., Rook, G. A., and Playfair, J. H., Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin. Exp. Immunol. 76, 240-245, 1989.
18. 16. Takashima, T., Ueta, C., Tsuyuguchi, I., and Kishimoto, S., Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis. Infect. Immun. 58, 3286-3292, 1990.
19. 17. Wallis, R. S., Amir-Tahmasseb, M., and Ellner, J. J., Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: The monocyte western blot. Proc. Natl. Acad. Sci. USA 87, 3348-3352, 1990.
20. 18. Ogawa, T., Uchida, H., Kusumoto, Y., Mori, Y., Yamamura, Y., and Hamada, S., Increase in tumor necrosis factor alpha-and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect. Immun. 59, 3021-3025, 1991.
21. 19. Zhang, Y., Doerfler, M., Lee, T. C., Guillemin, B., and Rom, W. N., Mechanisms of stimulation of interleukin-1 and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Invest. 91, 2076-2083, 1993.
22. 20. Schauf, V., Rom, W. N., Smith, K. A., Sampaio, E. P., Meyn, P. A., Tramontana, J. M., Cohn, Z. A., and Kaplan, G., Cytokine gene activation and modified responsiveness to IL-2 in the blood of tuberculosis patients. J. Infect. Dis. 168, 1056-1059, 1993.
23. 21. Bermudez, L. E., and Kaplan, G., Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3, 22-26, 1995.
24. 22. Beutler, B., and Cerami, A., The common mediator of shock, cachexia and tumor necrosis. Adv. Immunol. 42, 213-231, 1988.
25. 23. Tracey, K. J., and Cerami, A., Tumor necrosis factor in the malnutrition (cachexia) of infection and cancer. Am. J. Trop. Med. Hyg. 47(Suppl.), 2-7, 1992.
26. 24. Tramontana, J. M., Utaipat, U., Molloy, A., Akarasewi, P., Burroughs, M., Makonkawkeyoon, S., Johnson, B., Klausner, J., Rom, W., and Kaplan, G., Thalidomide treatment reduces tumor necrosis factor α production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med. 1, 384-397, 1995.
27. 25. Lahdevirta, J., Maury, C. P. J., Teppo, A. M., and Repo, H., Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85, 289-291, 1988.
28. 26. Hober, D., Haque, A., Wattre, P., Beaucaire, G., Mouton, Y., and Capron, A., Production of tumour necrosis factor-alpha (TNF-α) and interleukin 1 (IL-1) in patients with AIDS: Enhanced level of TNF-α is related to a higher cytotoxic activity. Clin. Exp. Immunol. 78, 329-333, 1989.
29. 27. Kobayashi, S., Hamamoto, Y., Kobayashi, N., and Yamamoto, N., Serum levels of TNF-α in HIV-infected individuals. AIDS 4, 169-170, 1990.
30. 28. Godfried, M. H., van der Poll, T., Weverling, G. J., et al., Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 169, 739-745, 1994.
31. 29. Clouse, K. A., Powell, D., Washington, I., Poli, G., Strebel, K., Farrar, W., Barstad, P., Kovacs, J., Fauci, A. S., and Folks, T. M., Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142, 431-438, 1989.
32. 30. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H., and Fauci, A. S., Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86, 2365-2368, 1989.
33. 31. Michihiko, S., Yamamoto, N., Shinozaki, F., Shimada, K., Soma, G. I., and Kobayashi, N., Augmentation of in vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumour necrosis factor. Lancet 1, 1206-1207, 1989.
34. 32. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., and Rabson, A. B., Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86, 5974-5978, 1989.
35. 33. Matsuyama, T., Kobayashi, N., and Yamamoto, N., Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease? AIDS 5, 1405-1417, 1991.
36. 34. Makonkawkeyoon, S., Limson-Pobre, R. N. R., Moreira, A. L., Schauf, V., and Kaplan, G., Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 5974-5978, 1993.
37. 35. Klausner, J. D., Makonkawkeyoon, S., Akarasewi, P., Nakata, K., Kasinrerk, W., Corral, L., Dewar, R. L., Lane, H. C., Freedman, V. H., and Kaplan, G. The effect of thalidomide on the pathogenesis of HIV-1 and M. tuberculosis infection. J. AIDS Hum. Retroviruses 11, 247-257, 1996.